Business · 17/02/2022Updated: 10/17/2026 · 1 min read
FDA Awards Priority Review Voucher to ModernaTX for COVID-19 Vaccine SPIKEVAX
Summary
The FDA has issued a priority review voucher to ModernaTX, Inc., the manufacturer of SPIKEVAX, a COVID-19 vaccine, following a review of its material threat medical countermeasure product application.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →